The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer

Progestin therapy is the main fertility-sparing treatment for women with endometrial cancer (EC) and atypical endometrial hyperplasia (AEH). However, still 15-25% of these women failed to achieve complete response (CR) and then lost their fertility after definitive surgery. Metformin has been demons...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jun, Chen, Xiao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646621/
https://www.ncbi.nlm.nih.gov/pubmed/36387903
http://dx.doi.org/10.3389/fendo.2022.1041535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646621/
https://www.ncbi.nlm.nih.gov/pubmed/36387903
http://dx.doi.org/10.3389/fendo.2022.1041535

Ejemplares similares